Wednesday - March 11, 2026
ERIC Applauds FDA Action on Biosimilars to Reduce Drug Costs
March 11, 2026
WASHINGTON, March 11 -- The ERISA Industry Committee issued the following statement on March 10, 2026:

* * *

ERIC Applauds FDA Action on Biosimilars to Reduce Drug Costs

The ERISA Industry Committee (ERIC) issued the following statement today regarding the Trump Administration's announcement to make biosimilar development faster and more affordable. The statement can be attributed to ERIC President and CEO, James Gelfand.

"Biosimilars . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products